Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
F Davodabadi, SF Sajjadi, M Sarhadi… - European Journal of …, 2023 - Elsevier
Conventional chemotherapy, one of the most widely used cancer treatment methods, has
serious side effects, and usually results in cancer treatment failure. Drug resistance is one of …
serious side effects, and usually results in cancer treatment failure. Drug resistance is one of …
Endogenous opiates and behavior: 2021
RJ Bodnar - Peptides, 2023 - Elsevier
This paper is the forty-fourth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …
research concerning the endogenous opioid system, summarizing articles published during …
GPR171 agonist reduces chronic neuropathic and inflammatory pain in male, but not female mice
Chronic pain is a growing public health crisis that requires exigent and efficacious
therapeutics. GPR171 is a promising therapeutic target that is widely expressed through the …
therapeutics. GPR171 is a promising therapeutic target that is widely expressed through the …
Efficient Generation of Genome-wide Libraries for Protein–ligand Screens Using Gibson Assembly
T Sternlieb, M Loock, M Gao, I Cestari - Bio-protocol, 2022 - bio-protocol.org
Genome-wide screens using yeast or phage displays are powerful tools for identifying
protein–ligand interactions, including drug or vaccine targets, ligand receptors, or protein …
protein–ligand interactions, including drug or vaccine targets, ligand receptors, or protein …
The periaqueductal grey in opioid tolerance and chronic pain
A Ram - 2021 - search.proquest.com
Pain is the body's natural warning system to indicate one is in an environment highly
detrimental to survival. The body's response to the sensation of pain is to immediately …
detrimental to survival. The body's response to the sensation of pain is to immediately …
Investigating the role of JARID2 in treatment resistance in glioblastoma
MMH Al-Jabri - 2023 - etheses.whiterose.ac.uk
Glioblastoma (GBM) is the deadliest primary brain tumour in adults with a median survival of
14-20 months from initial diagnosis. Despite aggressive treatment involving maximal …
14-20 months from initial diagnosis. Despite aggressive treatment involving maximal …